Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer

Colorectal Disease

Volumn 16, Issue 5, 2014, Pages 359-367

  Segelman, J ^a   Akre, O ^a   Gustafsson, U O ^b   Bottai, M ^a   Martling, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Individual risk; Peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METACHRONOUS PERITONEAL CARCINOMATOSIS; MULTIMODALITY CANCER THERAPY; PREDICTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SECOND LOOK SURGERY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGE; CARCINOMA; COLONIC NEOPLASMS; ELECTIVE SURGERY; EMERGENCY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; NOMOGRAM; PATHOLOGY; PERITONEAL NEOPLASMS; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RECTAL NEOPLASMS; RISK ASSESSMENT; RISK FACTOR; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; ELECTIVE SURGICAL PROCEDURES; EMERGENCIES; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NOMOGRAMS; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SECOND-LOOK SURGERY; YOUNG ADULT;

EID: 84898417825     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12552     Document Type: Article

References (20)

1. Verwaal VJ, van Ruth S, de Bree E et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-43.
2. Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ 3rd. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116: 3756-62.
3. Elias D, Gilly F, Boutitie F et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-8.
4. Elias D, Lefevre JH, Chevalier J et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681-5.
5. da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203: 878-86.
6. Dromain C, Leboulleux S, Auperin A et al. Staging of peritoneal carcinomatosis: enhanced CT vs PET/CT. Abdom Imaging 2008; 33: 87-93.
7. de Bree E, Koops W, Kroger R, van Ruth S, Witkamp AJ, Zoetmulder FA. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004; 86: 64-73.
8. Honore C, Goere D, Souadka A, Dumont F, Elias D. Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 2013; 20: 183-92.
9. Brucher B, Stojadinovic A, Bilchik A et al. Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy. J Cancer 2013; 4: 262-9.
10. Sugarbaker PH. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care. Surg Oncol Clin N Am 2012; 21: 689-703.
11. Elias D, Honore C, Dumont F et al. Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2011; 254: 289-93.
12. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 2012; 99: 699-705.
13. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
14. Valentini V, van Stiphout RG, Lammering G et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 2011; 29: 3163-72.
15. Weiser MR, Landmann RG, Kattan MW et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008; 26: 380-5.
16. Kattan MW, Gonen M, Jarnagin WR et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247: 282-7.
17. Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer 2011; 128: 2717-25.
18. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-50.
19. Willett C, Tepper JE, Cohen A, Orlow E, Welch C. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985; 3: 379-84.
20. Slanetz CA Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984; 27: 792-7.